Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 55
Filtrar
1.
Bull Exp Biol Med ; 176(6): 747-750, 2024 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-38888651

RESUMO

In in vitro model of short-term therapeutic inhalation of Xe/O2 mixture, xenon in millimolar concentrations led to a pronounced decrease in induced platelet aggregation in the platelet-enriched blood plasma. The maximum and statistically significant decrease occurred in response to induction by collagen (by ≈30%, p≤0.01) and ADP (by ≈25%, p≤0.01). A slightly weaker but statistically significant reduction in aggregation appeared in response to ristocetin (by ≈12%, p≤0.01) and epinephrine (by ≈9%, p≤0.01). It should be noted that the spontaneous aggregation exceeded the reference values in the control group. Nevertheless, even at minimal absolute values, spontaneous platelet aggregation decreased by 2 times in response to xenon (p≤0.01). The reasons for the decrease of spontaneous and induced aggregation are xenon accumulation in the lipid bilayer of the membrane with subsequent nonspecific (mechanical) disassociation of membrane platelet structures and specific block of its distinct from neuronal NMDA receptor.


Assuntos
Agregação Plaquetária , Xenônio , Xenônio/farmacologia , Agregação Plaquetária/efeitos dos fármacos , Humanos , Plaquetas/efeitos dos fármacos , Plaquetas/metabolismo , Difosfato de Adenosina/farmacologia , Inibidores da Agregação Plaquetária/farmacologia , Plasma Rico em Plaquetas/metabolismo , Epinefrina/farmacologia , Epinefrina/sangue , Colágeno/metabolismo
2.
Bull Exp Biol Med ; 174(3): 333-336, 2023 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-36723753

RESUMO

We studied the effect of an indolinone derivative GRS on the development of experimental atherosclerosis in C57BL/6 mice. Atherosclerosis was modeled by intraperitoneal administration of endothelial lipoprotein lipase inhibitor Kolliphor P 407 micro Geismar over 5 months. GRS was administered orally in a dose of 10 mg/kg once a day throughout the experiment. In 5 months, the levels of total cholesterol, LDL, and triglycerides in blood serum, as well as histological composition of the ascending aorta were studied. In mice with experimental atherosclerosis, we observed pronounced dyslipidemia with an increase in serum cholesterol, LDL, and triglycerides and accumulation of xanthoma cells in the aorta wall. Repeat administration of GRS did not eliminate dyslipidemia, but prevented an increase in the number of xanthoma cells in the aorta wall (p<0.05). The stimulator of soluble guanylate cyclase GRS did not exhibit hypolipidemic activity, but restored impaired endothelial function in the atherosclerosis model and prevented atherosclerotic damage to blood vessels and vascular wall remodeling.


Assuntos
Aterosclerose , Dislipidemias , Xantomatose , Camundongos , Animais , Guanilil Ciclase Solúvel , LDL-Colesterol , Camundongos Endogâmicos C57BL , Aterosclerose/tratamento farmacológico , Triglicerídeos , Dislipidemias/tratamento farmacológico , Guanilato Ciclase
3.
Bull Exp Biol Med ; 172(6): 691-694, 2022 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-35501647

RESUMO

Experimental type 1 diabetes mellitus (T1DM) was induced in rats by daily intraperitoneal injections of alloxan in a dose of 90 mg/kg for 4 days. For verification of insulin resistance, insulin tolerance test was performed in 2 weeks and the glucose utilization rate constant (KITT) was calculated. The rats demonstrated the main symptoms of T1DM: hypoinsulinemia, hyperglycemia, ketonemia, glucosuria, ketonuria, polydipsia, polyphagia, weight loss, and insulin resistance, as evidenced by a decrease in KITT. The serum content of free fatty acids and triacylglycerols significantly increased. The content of triacylglycerols increased in skeletal muscles and decreased in the liver. A negative linear correlation was found between KITT and triacylglycerol content in muscles. Thus, the development of insulin resistance in experimental T1DM in rats is associated with accumulation of triacylglycerols in skeletal muscles.


Assuntos
Diabetes Mellitus Experimental , Diabetes Mellitus Tipo 1 , Resistência à Insulina , Animais , Glicemia , Diabetes Mellitus Tipo 1/induzido quimicamente , Insulina , Resistência à Insulina/fisiologia , Ratos , Triglicerídeos
4.
Bull Exp Biol Med ; 172(3): 364-367, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-35001305

RESUMO

The article presents a theoretical rationale and a clinical case of relief of post-COVID ventilation failure by inhalation of Xe and O2 gas mixture. Pneumonitis of coronavirus etiology transforms saturated phospholipids of surfactant into a solid-ordered phase, which disrupts surface tension, alveolar pneumatization, and alveolar-capillary gas exchange. Using molecular modeling (B3LYP/lanl2dz; GAUSSIAN09), we demonstrated that Xe atom due to the van der Waals dispersion interaction increases the distance between the phospholipid acyl chains providing a phase transition from the solid-ordered to liquid phase and restored the surface-active monolayer surfactant film. A clinical case confirmed that short-term inhalations of the Xe and O2 gas mixture relieved manifestations of ventilation insufficiency and increased SpO2 and pneumatization of the terminal parts of the lungs.


Assuntos
COVID-19/complicações , Oxigênio/administração & dosagem , Insuficiência Respiratória/terapia , Terapia Respiratória/métodos , Xenônio/administração & dosagem , Administração por Inalação , Anestésicos Inalatórios/administração & dosagem , COVID-19/etiologia , COVID-19/reabilitação , COVID-19/terapia , Combinação de Medicamentos , Humanos , Pulmão/efeitos dos fármacos , Pulmão/fisiopatologia , Masculino , Pessoa de Meia-Idade , Respiração/efeitos dos fármacos , Insuficiência Respiratória/etiologia , Federação Russa , SARS-CoV-2 , Síndrome de COVID-19 Pós-Aguda
5.
Bull Exp Biol Med ; 168(6): 739-742, 2020 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-32333310

RESUMO

Cytochrome p450-mediated metabolism of GRS (indolinone antiaggregant) and its effects on activities of cytochrome p450 isoenzymes were studied. Inhibition of 6 isomers of cytochrome p450 in human liver microsomes was studied with the use of specific substrates. It was found that human liver cytochrome p450 enzymes could not induce degradation of GRS and that GRS was not an inductor or inhibitor of cytochrome p450 family members 1A2, 2C9, 2C19, 2D6, 2C8, and 3A4. Hence, clinical use of the prospective antiaggregant would not involve the risk of uncontrolled fluctuations in GRS concentrations in the organism because of interactions between the drugs.


Assuntos
Microssomos Hepáticos/efeitos dos fármacos , Oxindóis/farmacologia , Inibidores da Agregação Plaquetária/farmacologia , Animais , Biotransformação/efeitos dos fármacos , Citocromo P-450 CYP1A2/metabolismo , Citocromo P-450 CYP2C19/metabolismo , Citocromo P-450 CYP2C8/metabolismo , Citocromo P-450 CYP2C9/metabolismo , Citocromo P-450 CYP2D6/metabolismo , Citocromo P-450 CYP3A/metabolismo , Ensaios Enzimáticos , Expressão Gênica , Humanos , Cinética , Fígado/efeitos dos fármacos , Fígado/enzimologia , Microssomos Hepáticos/enzimologia , NADP/metabolismo , Ratos , Verapamil/farmacologia
6.
Bull Exp Biol Med ; 167(2): 201-206, 2019 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-31236885

RESUMO

The role of NF-κB, cAMP/PKA, JAKs/STAT3, ERK1/2, p38, JNK, and p53 signaling pathways in the realization of growth potential of mesenchymal, neural, erythroid, and granulomonocytic progenitor cells were examined in vitro. Using selective blockers of signaling molecules, we revealed some principal distinctions of their involvement in determination of proliferation-differentiation status of the progenitor cells of different functional classes. The most salient peculiarities were observed in the roles of cAMP/PKA, JNK, and JAKs/STAT3 signaling pathways in the control of functions of various types of the regeneration-competent elements. The specific features of intracellular signaling revealed in histogenetically and functionally different progenitor cells attest to visibility of differentiated pharmacological stimulation of regeneration in individual tissues and prospectiveness in the development of targeted remedies for regenerative medicine based on modifiers of activity of the intracellular signaling molecules.


Assuntos
Células-Tronco Hematopoéticas/metabolismo , Células-Tronco Mesenquimais/metabolismo , Células-Tronco Neurais/metabolismo , Transdução de Sinais/efeitos dos fármacos , Animais , Antracenos/farmacologia , Antraquinonas/farmacologia , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Didesoxiadenosina/farmacologia , Diterpenos do Tipo Caurano/farmacologia , Flavonoides/farmacologia , Células-Tronco Hematopoéticas/efeitos dos fármacos , Janus Quinases/metabolismo , Células-Tronco Mesenquimais/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Proteínas Quinases Ativadas por Mitógeno , NF-kappa B/metabolismo , Células-Tronco Neurais/efeitos dos fármacos , Nitrilas , Fosforilação/efeitos dos fármacos , Pirazóis/farmacologia , Pirimidinas , Medicina Regenerativa , Fator de Transcrição STAT3/metabolismo , Sulfonamidas/farmacologia
7.
Bull Exp Biol Med ; 165(5): 665-668, 2018 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-30225700

RESUMO

JAK/STAT signaling pathway was examined comparatively during realization of growth potential of mesenchymal progenitor cells stimulated with diterpene alkaloid songorine or fibroblast growth factor. The stimulating role of JAKs and STAT3 on the mitotic activity and differentiation of progenitor cells cultured with songorine was revealed. Under these conditions, the study demonstrated suppression of fibroblast colony formation against the background of reduced number of actively proliferating CFU-fibroblasts and a drop of differentiation index of progenitor cells induced by pan-JAKs and STAT3 inhibitors. The observed changes were in almost complete agreement with the character of functional reactions of the progenitor elements in response to blockade of JAKs and STAT3 with fibroblast growth factor. In addition, blockade of JAKs with this factor enhanced the differentiation rate of the progenitor cells.


Assuntos
Aconitum/química , Alcaloides/farmacologia , Janus Quinases/genética , Células-Tronco Mesenquimais/efeitos dos fármacos , Fator de Transcrição STAT3/genética , Alcaloides/isolamento & purificação , Animais , Antraquinonas/farmacologia , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Fatores de Crescimento de Fibroblastos/farmacologia , Regulação da Expressão Gênica , Janus Quinases/antagonistas & inibidores , Janus Quinases/metabolismo , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Nitrilas , Fosforilação/efeitos dos fármacos , Extratos Vegetais/química , Cultura Primária de Células , Pirazóis/farmacologia , Pirimidinas , Fator de Transcrição STAT3/antagonistas & inibidores , Fator de Transcrição STAT3/metabolismo , Transdução de Sinais , Sulfonamidas/farmacologia
8.
Kardiologiia ; (S5): 20-29, 2018.
Artigo em Russo | MEDLINE | ID: mdl-29894673

RESUMO

PURPOSE OF THE STUDY: To compare the effect of loading doses of atorvastatin and rosuvastatin on the value of the acute kidney injury and acute inflammatory response to elective percutaneous coronary interventions. MATERIALS AND METHODS: An open prospective comparative study included 68 patients referred for elective percutaneous coronary intervention (PCI). At baseline, all patients had been taking statins for a long time as a standard lipid-lowering therapy. The first group included 33 patients who received a loading dose of 80 mg of atorvastatin (As) 12 hours before the intervention with saving this dose for 2-6 days. The second group included 35 patients treated with rosuvastatin (Rs) 40 mg / day in the same manner. The levels of creatinine and cystatin C in the blood were determined at baseline and 12, 24, 48 and 72 hours after the intervention. HsCRP level was determined at baseline and 72 hours after PCI. RESULTS: AKI was diagnosed in 5 patients (7.94 %): 4 patients (12.1 %) in group As and 1 patient (3.3 %) in group Rs (p = 0.36). The increase of serum creatinine level in the group As patients was 43.4 % higher than one in the Rs group patients (p = 0.024). The decrease of glomerular filtration rate (GFR) in group As was 15.5 % higher than one in group Rs (p = 0.09). Initially, the level of cystatin C in the groups did not differ (698.9 (560.2-869.6) ng / ml in group As vs 759.5 (673.8-899.9) ng/ml in group Rs, p = 0.75). Significant intergroup differences were found in the level of serum cystatin C 12 hours after PCI (718.3 (555.6-839.6) ng/ml in group As vs 470.6 (378.2-689.4) ng/ml in the Rs group, p = 0.007) that persisted 24 hours after the intervention (732.1 (632.3-887) ng/ml vs 526.4 (357.4-802.7) ng/ml, respectively, p = 0.02). From the second day after PCI, intergroup differences in serum cystatin C disappeared. The level of hsCRP significantly increased 72 hours after the intervention in group As (1.65 (0.9-4) mg/l at baseline vs 4.55 (1.6-8.7) mg/l 72 hours after PCI, p = 0.01). The level of hsCRP did not change significantly at the same time in the Rs group (2.8 (0.8-6.8) mg/l at baseline vs 2.75 (1.5-6.5) mg/l 72 hours after PCI, p = 0.16). CONCLUSION: The loading dose of rosuvastatin better prevents periprocedural kidney injury in PCI and more significantly reduces the overall inflammatory response to intervention compared to the loading dose of atorvastatin.


Assuntos
Inibidores de Hidroximetilglutaril-CoA Redutases , Intervenção Coronária Percutânea , Humanos , Estudos Prospectivos
9.
Bull Exp Biol Med ; 165(2): 213-215, 2018 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-29923009

RESUMO

А cross-sectional study was performed on a continuous sample of patients (N=52) with the gastroesophageal reflux disease. Specific features of this disease in patients with overweight were revealed. Regurgitation predominated in the structure of complaints. Fibrogastroduodenoscopy revealed endoscopically negative form of the diseases in 38% of cases. According to 24-h pH monitoring results, alkaline reflux pH>7 took more than 25% time in supine position at high DeMeester score, which limits the usage of aggressive acid-lowering therapy.


Assuntos
Refluxo Gastroesofágico/complicações , Refluxo Gastroesofágico/epidemiologia , Sobrepeso/complicações , Sobrepeso/epidemiologia , Adulto , Índice de Massa Corporal , Estudos Transversais , Endoscopia Gastrointestinal , Esôfago/metabolismo , Esôfago/patologia , Feminino , Refluxo Gastroesofágico/diagnóstico , Refluxo Gastroesofágico/terapia , Humanos , Concentração de Íons de Hidrogênio , Masculino , Pessoa de Meia-Idade , Sobrepeso/diagnóstico , Sobrepeso/terapia , Medicina de Precisão , Índice de Gravidade de Doença , Adulto Jovem
10.
Bull Exp Biol Med ; 165(1): 18-21, 2018 May.
Artigo em Inglês | MEDLINE | ID: mdl-29797128

RESUMO

JAK/STAT signaling pathway was examined during functional stimulation of mesenchymal progenitor cells with fibroblast growth factor. The differences were observed in the realizations of the proliferation-differentiation potential of CFU-fibroblasts under blockade of JAKs or during selective inactivation of STAT3. The study revealed stimulating influences of JAKs and STAT3 on mitotic activity of progenitor cells and individual roles of these proteins in the control of their maturation. Blockade of JAKs diminished the level of fibroblast colony formation and the score of actively proliferating CFU-fibroblasts at the background increase of the differentiation rate of progenitor cells. In contrast, STAT3 inhibitor resulted in a coordinated decrease of all examined parameters.


Assuntos
Fatores de Crescimento de Fibroblastos/farmacologia , Janus Quinases/metabolismo , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/metabolismo , Fator de Transcrição STAT3/metabolismo , Animais , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Camundongos Endogâmicos C57BL , Fosforilação/efeitos dos fármacos , Medicina Regenerativa , Transdução de Sinais/efeitos dos fármacos
11.
Bull Exp Biol Med ; 164(3): 316-319, 2018 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-29308566

RESUMO

The role of JAK/STAT3-mediated signaling pathway in the realization of the growth potential of mesenchymal precursor cells was examined in vitro. The stimulating role of JAKs and STAT3 towards proliferating activity of progenitor cells and their different role in the regulation of differentiation of the progenitor elements were demonstrated. Inhibitors of JAKs and STAT3 reduced the yield of fibroblast CFU and their mitotic activity. Blockade of JAKs accelerated and selective inactivation of STAT3 decelerated differentiation of progenitor cells.


Assuntos
Células da Medula Óssea/metabolismo , Fibroblastos/metabolismo , Janus Quinase 1/genética , Janus Quinase 3/genética , Células-Tronco Mesenquimais/metabolismo , Fator de Transcrição STAT3/genética , Animais , Antraquinonas/farmacologia , Células da Medula Óssea/citologia , Células da Medula Óssea/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Regulação da Expressão Gênica , Janus Quinase 1/antagonistas & inibidores , Janus Quinase 1/metabolismo , Janus Quinase 3/antagonistas & inibidores , Janus Quinase 3/metabolismo , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Nitrilas , Fosforilação , Cultura Primária de Células , Pirazóis/farmacologia , Pirimidinas , Fator de Transcrição STAT3/antagonistas & inibidores , Fator de Transcrição STAT3/metabolismo , Transdução de Sinais , Sulfonamidas/farmacologia
12.
Bull Exp Biol Med ; 163(4): 443-446, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28853089

RESUMO

We studied the role of some JAK in the effect of diterpene alkaloid songorine on realization of the growth potential of mesenchymal precursor cells. The participation of JAK1, JAK2, and JAK3 in stimulation of proliferation of the precursor cells was demonstrated. Specific inhibitors of these JAK reduced the yield of fibroblast CFU and the rate of their division. Inhibition of JAK2 against the background of songorine treatment increased the rate of precursor differentiation.


Assuntos
Alcaloides/farmacologia , Janus Quinase 1/metabolismo , Janus Quinase 2/metabolismo , Janus Quinase 3/metabolismo , Animais , Diferenciação Celular/efeitos dos fármacos , Humanos , Janus Quinase 1/genética , Janus Quinase 2/genética , Janus Quinase 3/genética , Células-Tronco Mesenquimais/efeitos dos fármacos , Células-Tronco Mesenquimais/metabolismo , Inibidores de Proteínas Quinases/farmacologia , Medicina Regenerativa/métodos , Transdução de Sinais/fisiologia , Células-Tronco/citologia , Células-Tronco/metabolismo
13.
Bull Exp Biol Med ; 162(2): 240-243, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27905037

RESUMO

We studied the involvement of individual JAK kinases in the realization of the growth potential of mesenchymal precursors under the effect of fibroblast growth factor. The important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells and participation of JAK1 in this process under conditions of cytokine stimulation of progenitor cells were demonstrated. Specific inhibitors of these kinases reduced the yield of fibroblast CFU and the rate of their division. Moreover, blockade of JAK1, JAK2, and JAK3 under the effect of fibroblast growth factor was accompanied by an increase in the intensity of progenitor cell differentiation.


Assuntos
Fatores de Crescimento de Fibroblastos/farmacologia , Janus Quinase 1/genética , Janus Quinase 2/genética , Janus Quinase 3/genética , Células-Tronco Mesenquimais/efeitos dos fármacos , Animais , Células da Medula Óssea/citologia , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/enzimologia , Diferenciação Celular/efeitos dos fármacos , Ensaio de Unidades Formadoras de Colônias , Fibroblastos/citologia , Fibroblastos/efeitos dos fármacos , Fibroblastos/enzimologia , Regulação da Expressão Gênica , Janus Quinase 1/antagonistas & inibidores , Janus Quinase 1/metabolismo , Janus Quinase 2/antagonistas & inibidores , Janus Quinase 2/metabolismo , Janus Quinase 3/antagonistas & inibidores , Janus Quinase 3/metabolismo , Masculino , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/enzimologia , Camundongos , Camundongos Endogâmicos CBA , Piperidinas/farmacologia , Cultura Primária de Células , Inibidores de Proteínas Quinases/farmacologia , Pirimidinas/farmacologia , Pirróis/farmacologia , Transdução de Sinais , Tirfostinas/farmacologia
14.
Bull Exp Biol Med ; 161(3): 367-70, 2016 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-27502536

RESUMO

Mice with Lewis lung carcinoma were used to study the antitumor and antimetastatic effects of JAK3 inhibitor. The study revealed no effect of JAK3 inhibitor on the growth of primary tumor node, but found a pronounced inhibition of hematogenous spread of the pathologic process into the lungs. In vitro blockade of JAK3 in cultured Lewis lung carcinoma produced no effect on the count of the stem tumor cells and stimulated functions of committed elements. In addition, blockade of JAK3 significantly elevated maturation index of the tumor tissue.


Assuntos
Carcinoma Pulmonar de Lewis/tratamento farmacológico , Carcinoma Pulmonar de Lewis/enzimologia , Inibidores Enzimáticos/uso terapêutico , Janus Quinase 3/antagonistas & inibidores , Animais , Inibidores Enzimáticos/farmacologia , Feminino , Camundongos , Camundongos Endogâmicos C57BL , Células-Tronco Neoplásicas/efeitos dos fármacos , Células-Tronco Neoplásicas/metabolismo
15.
Bull Exp Biol Med ; 161(2): 224-7, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-27383175

RESUMO

Involvement of individual JAK kinases in the realization of growth potential of mesenchymal progenitor cells was examined in vitro. Important role of JAK2 and JAK3 in determining the initial level of mitotic activity of progenitor cells was established. The yield of fibroblast CFUF was suppressed under the effect of specific inhibitors of JAK kinases. Blockade of JAK3 increased the rate of progenitor element differentiation. JAK1 had no effect on proliferation and differentiation status of progenitor cells.


Assuntos
Diferenciação Celular , Proliferação de Células , Janus Quinases/fisiologia , Células-Tronco Mesenquimais/enzimologia , Animais , Células Cultivadas , Sistema de Sinalização das MAP Quinases , Masculino , Camundongos Endogâmicos CBA
16.
Bull Exp Biol Med ; 160(1): 64-7, 2015 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-26608375

RESUMO

The role of JNK-mediated signal pathway and participation of p53 transcription factor in stimulation of realization of the growth potential of the mesenchymal precursor cells by alkaloid songorine were examined in vitro. Specific inhibitors of JNK and p53 enhanced stimulation of fibroblast colony/cluster formation and proliferative activity of mesenchymal precursor cells. Under these conditions, more pronounced effects were observed with early precursors of fibroblast CFU and in both cases were accompanied by a decrease in differentiation index of progenitor elements.


Assuntos
Alcaloides/farmacologia , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Células-Tronco Mesenquimais/efeitos dos fármacos , Proteína Supressora de Tumor p53/fisiologia , Animais , Apoptose/efeitos dos fármacos , Benzotiazóis/farmacologia , Células Cultivadas , Ensaio de Unidades Formadoras de Colônias , Proteínas Quinases JNK Ativadas por Mitógeno/antagonistas & inibidores , Sistema de Sinalização das MAP Quinases/fisiologia , Masculino , Células-Tronco Mesenquimais/metabolismo , Camundongos , Camundongos Endogâmicos CBA , Inibidores de Proteínas Quinases/farmacologia , Tolueno/análogos & derivados , Tolueno/farmacologia , Proteína Supressora de Tumor p53/antagonistas & inibidores
17.
Bull Exp Biol Med ; 159(5): 642-5, 2015 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-26472093

RESUMO

The role of cAMP- and IKK-2-dependent pathways in stimulation of the growth capacity of mesenchymal progenitor cells with alkaloid songorine was studied in vitro. Inhibitors of adenylate cyclase and IKK-2 were shown to abolish the increase in proliferative activity of progenitor cells. Moreover, blockade of the inhibitory kinase complex was accompanied by a decrease in the intensity of progenitor cell differentiation.


Assuntos
Adenilil Ciclases/genética , Alcaloides/farmacologia , AMP Cíclico/metabolismo , Quinase I-kappa B/genética , Células-Tronco Mesenquimais/efeitos dos fármacos , Adenilil Ciclases/metabolismo , Animais , Diferenciação Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , AMP Cíclico/antagonistas & inibidores , Didesoxiadenosina/análogos & derivados , Didesoxiadenosina/farmacologia , Inibidores Enzimáticos/farmacologia , Regulação da Expressão Gênica , Quinase I-kappa B/antagonistas & inibidores , Quinase I-kappa B/metabolismo , Masculino , Células-Tronco Mesenquimais/citologia , Células-Tronco Mesenquimais/metabolismo , Camundongos , Camundongos Endogâmicos CBA , Cultura Primária de Células , Transdução de Sinais , Células-Tronco , Tiofenos/farmacologia
18.
Bull Exp Biol Med ; 159(4): 479-81, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26388570

RESUMO

The role of JNK-mediated signal pathway and participation of p53 transcription factor in stimulation of mesenchymal precursor cell function by the fibroblast growth factor was studied. The levels of fibroblast colony- and cluster formation and proliferative activity of mesenchymal precursors increased in response to JNK and p53 specific inhibitors. JNK and p53 blockers did not change the rate of fibroblast growth factor-induced progenitor element differentiation.


Assuntos
Fatores de Crescimento de Fibroblastos/fisiologia , MAP Quinase Quinase 4/metabolismo , Células-Tronco Mesenquimais/fisiologia , Proteína Supressora de Tumor p53/fisiologia , Animais , Proliferação de Células , Células Cultivadas , Masculino , Camundongos Endogâmicos CBA , Transdução de Sinais
19.
Bull Exp Biol Med ; 159(1): 58-61, 2015 May.
Artigo em Inglês | MEDLINE | ID: mdl-26033591

RESUMO

We studied the role of intracellular signaling molecules PI3K, МАРK ERK1/2, and р38 in stimulation of realization of the growth potential of mesenchymal progenitor cells by alkaloid songorine in vitro. Inhibitors of PI3K, ERK1/2 and р38 canceled the increase in proliferative activity of progenitor cells, the blockers of ERK1/2 and р38 reduced the intensity of progenitor cell differentiation.


Assuntos
Alcaloides/farmacologia , Sistema de Sinalização das MAP Quinases/fisiologia , Células-Tronco Mesenquimais/efeitos dos fármacos , Animais , Células da Medula Óssea/efeitos dos fármacos , Células da Medula Óssea/enzimologia , Divisão Celular/efeitos dos fármacos , Células Cultivadas , Cromonas/farmacologia , Ensaio de Unidades Formadoras de Colônias , Flavonoides/farmacologia , Imidazóis/farmacologia , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Células-Tronco Mesenquimais/enzimologia , Camundongos , Camundongos Endogâmicos CBA , Proteína Quinase 1 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 1 Ativada por Mitógeno/fisiologia , Proteína Quinase 3 Ativada por Mitógeno/antagonistas & inibidores , Proteína Quinase 3 Ativada por Mitógeno/fisiologia , Modelos Biológicos , Morfolinas/farmacologia , Fosfatidilinositol 3-Quinases/fisiologia , Inibidores de Fosfoinositídeo-3 Quinase , Inibidores de Proteínas Quinases/farmacologia , Piridinas/farmacologia , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia , Proteínas Quinases p38 Ativadas por Mitógeno/antagonistas & inibidores , Proteínas Quinases p38 Ativadas por Mitógeno/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA